Cabergoline
NDC 50742-118, Cabergoline, tablet, from Ingenus Pharmaceuticals, LLC.
- Product NDC
- 50742-118
- Status
- Listed
- Labeler
- Ingenus Pharmaceuticals, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204735
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50742-118 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CABERGOLINE.5 mg/1
Pharmacologic classes
Ergolines [CS]; Ergot Derivative [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50742-118-08 | 50742011808 | 8 TABLET in 1 BOTTLE (50742-118-08) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/57cbd81e-fdb9-4060-80ee-6e8581c463a4NADAC price for package 50742011808
GET /v1/drugs/nadac/50742011808
Use it
Look up 50742-118 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50742-118 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50742-118. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.